[English] 日本語
Yorodumi
- EMDB-41235: VMAT1 dimer with MPP+ and reserpine -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: EMDB / ID: EMD-41235
TitleVMAT1 dimer with MPP+ and reserpine
Map dataVMAT1 dimer with MPP and reserpine
Sample
  • Complex: Complex of VMAT1 with MPP+ and Reserpine
    • Protein or peptide: Chromaffin granule amine transporter
  • Ligand: 1-methyl-4-phenylpyridin-1-ium
  • Ligand: reserpine
KeywordsVMAT / SLC18 / vascular monoamine transporter / monoamines / neurotransmitters / MPP+ / MEMBRANE PROTEIN
Function / homology
Function and homology information


norepinephrine uptake / monoamine:proton antiporter activity / aminergic neurotransmitter loading into synaptic vesicle / dopamine uptake / clathrin-sculpted monoamine transport vesicle membrane / serotonin:sodium:chloride symporter activity / Na+/Cl- dependent neurotransmitter transporters / monoamine transmembrane transporter activity / serotonin uptake / monoamine transport ...norepinephrine uptake / monoamine:proton antiporter activity / aminergic neurotransmitter loading into synaptic vesicle / dopamine uptake / clathrin-sculpted monoamine transport vesicle membrane / serotonin:sodium:chloride symporter activity / Na+/Cl- dependent neurotransmitter transporters / monoamine transmembrane transporter activity / serotonin uptake / monoamine transport / xenobiotic transmembrane transporter activity / secretory granule membrane / terminal bouton / synaptic vesicle membrane / presynapse / endoplasmic reticulum membrane
Similarity search - Function
Multidrug resistance protein / Major facilitator superfamily / Major Facilitator Superfamily / Major facilitator superfamily domain / Major facilitator superfamily (MFS) profile. / MFS transporter superfamily
Similarity search - Domain/homology
Chromaffin granule amine transporter
Similarity search - Component
Biological speciesHomo sapiens (human)
Methodsingle particle reconstruction / cryo EM / Resolution: 3.6 Å
AuthorsYe J / Liu B / Li W
Funding support United States, 1 items
OrganizationGrant numberCountry
American Heart AssociationEstablished Investigator Award United States
CitationJournal: Nature / Year: 2024
Title: Structural insights into vesicular monoamine storage and drug interactions.
Authors: Jin Ye / Huaping Chen / Kaituo Wang / Yi Wang / Aaron Ammerman / Samjhana Awasthi / Jinbin Xu / Bin Liu / Weikai Li /
Abstract: Biogenic monoamines-vital transmitters orchestrating neurological, endocrinal and immunological functions-are stored in secretory vesicles by vesicular monoamine transporters (VMATs) for controlled ...Biogenic monoamines-vital transmitters orchestrating neurological, endocrinal and immunological functions-are stored in secretory vesicles by vesicular monoamine transporters (VMATs) for controlled quantal release. Harnessing proton antiport, VMATs enrich monoamines around 10,000-fold and sequester neurotoxicants to protect neurons. VMATs are targeted by an arsenal of therapeutic drugs and imaging agents to treat and monitor neurodegenerative disorders, hypertension and drug addiction. However, the structural mechanisms underlying these actions remain unclear. Here we report eight cryo-electron microscopy structures of human VMAT1 in unbound form and in complex with four monoamines (dopamine, noradrenaline, serotonin and histamine), the Parkinsonism-inducing MPP, the psychostimulant amphetamine and the antihypertensive drug reserpine. Reserpine binding captures a cytoplasmic-open conformation, whereas the other structures show a lumenal-open conformation stabilized by extensive gating interactions. The favoured transition to this lumenal-open state contributes to monoamine accumulation, while protonation facilitates the cytoplasmic-open transition and concurrently prevents monoamine binding to avoid unintended depletion. Monoamines and neurotoxicants share a binding pocket that possesses polar sites for specificity and a wrist-and-fist shape for versatility. Variations in this pocket explain substrate preferences across the SLC18 family. Overall, these structural insights and supporting functional studies elucidate the mechanism of vesicular monoamine transport and provide the basis to develop therapeutics for neurodegenerative diseases and substance abuse.
History
DepositionJul 12, 2023-
Header (metadata) releaseMar 20, 2024-
Map releaseMar 20, 2024-
UpdateApr 10, 2024-
Current statusApr 10, 2024Processing site: RCSB / Status: Released

-
Structure visualization

Supplemental images

Downloads & links

-
Map

FileDownload / File: emd_41235.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES)
AnnotationVMAT1 dimer with MPP and reserpine
Voxel sizeX=Y=Z: 0.88533 Å
Density
Contour LevelBy AUTHOR: 0.08
Minimum - Maximum-0.001683045 - 2.0044067
Average (Standard dev.)0.0006782008 (±0.019164009)
SymmetrySpace group: 1
Details

EMDB XML:

Map geometry
Axis orderXYZ
Origin000
Dimensions320320320
Spacing320320320
CellA=B=C: 283.30664 Å
α=β=γ: 90.0 °

-
Supplemental data

-
Half map: VMAT1 dimer with MPP and reserpine

Fileemd_41235_half_map_1.map
AnnotationVMAT1 dimer with MPP and reserpine
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Half map: VMAT1 dimer with MPP and reserpine

Fileemd_41235_half_map_2.map
AnnotationVMAT1 dimer with MPP and reserpine
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Sample components

-
Entire : Complex of VMAT1 with MPP+ and Reserpine

EntireName: Complex of VMAT1 with MPP+ and Reserpine
Components
  • Complex: Complex of VMAT1 with MPP+ and Reserpine
    • Protein or peptide: Chromaffin granule amine transporter
  • Ligand: 1-methyl-4-phenylpyridin-1-ium
  • Ligand: reserpine

-
Supramolecule #1: Complex of VMAT1 with MPP+ and Reserpine

SupramoleculeName: Complex of VMAT1 with MPP+ and Reserpine / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 105.2 KDa

-
Macromolecule #1: Chromaffin granule amine transporter

MacromoleculeName: Chromaffin granule amine transporter / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 50.565641 KDa
Recombinant expressionOrganism: Komagataella pastoris (fungus)
SequenceString: MLRTILDAPQ RLLKEGRASR QLVLVVVFVA LLLDNMLFTV VVPIVPTFLY DMEFKEVNSS LHLGHAGSNC LQGTGFLEEE ITRVGVLFA SKAVMQLLVN PFVGPLTNRI GYHIPMFAGF VIMFLSTVMF AFSGTYTLLF VARTLQGIGS SFSSVAGLGM L ASVYTDDH ...String:
MLRTILDAPQ RLLKEGRASR QLVLVVVFVA LLLDNMLFTV VVPIVPTFLY DMEFKEVNSS LHLGHAGSNC LQGTGFLEEE ITRVGVLFA SKAVMQLLVN PFVGPLTNRI GYHIPMFAGF VIMFLSTVMF AFSGTYTLLF VARTLQGIGS SFSSVAGLGM L ASVYTDDH ERGRAMGTAL GGLALGLLVG APFGSVMYEF VGKSAPFLIL AFLALLDGAL QLCILQPSKV SPESAKGTPL FM LLKDPYI LVAAGSICFA NMGVAILEPT LPIWMMQTMC SPKWQLGLAF LPASVSYLIG TNLFGVLANK MGRWLCSLIG MLV VGTSLL CVPLAHNIFG LIGPNAGLGL AIGMVDSSMM PIMGHLVDLR HTSVYGSVYA IADVAFCMGF AIGPSTGGAI VKAI GFPWL MVITGVINIV YAPLCYYLRS PPAKEEKLAI LSQDCPMETR MYATQKPTKE FPLGEDSDEE PDHEE

UniProtKB: Chromaffin granule amine transporter, Chromaffin granule amine transporter

-
Macromolecule #2: 1-methyl-4-phenylpyridin-1-ium

MacromoleculeName: 1-methyl-4-phenylpyridin-1-ium / type: ligand / ID: 2 / Number of copies: 1 / Formula: WRF
Molecular weightTheoretical: 170.23 Da
Chemical component information

ChemComp-WRF:
1-methyl-4-phenylpyridin-1-ium

-
Macromolecule #3: reserpine

MacromoleculeName: reserpine / type: ligand / ID: 3 / Number of copies: 1 / Formula: YHR
Molecular weightTheoretical: 608.679 Da
Chemical component information

ChemComp-YHR:
reserpine

-
Experimental details

-
Structure determination

Methodcryo EM
Processingsingle particle reconstruction
Aggregation stateparticle

-
Sample preparation

BufferpH: 8
GridModel: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 60 sec. / Pretreatment - Atmosphere: AIR
VitrificationCryogen name: ETHANE

-
Electron microscopy

MicroscopeTFS KRIOS
Electron beamAcceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN
Electron opticsC2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy / Cs: 2.7 mm / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm / Nominal magnification: 130000
Specialist opticsEnergy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV
Sample stageSpecimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN
TemperatureMin: 63.0 K / Max: 77.2 K
Image recordingFilm or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 1 / Number real images: 6112 / Average exposure time: 2.0 sec. / Average electron dose: 50.0 e/Å2
Experimental equipment
Model: Titan Krios / Image courtesy: FEI Company

-
Image processing

Startup modelType of model: NONE
Initial angle assignmentType: MAXIMUM LIKELIHOOD
Final angle assignmentType: MAXIMUM LIKELIHOOD
Final reconstructionApplied symmetry - Point group: C1 (asymmetric) / Algorithm: SIMULTANEOUS ITERATIVE (SIRT) / Resolution.type: BY AUTHOR / Resolution: 3.6 Å / Resolution method: FSC 0.143 CUT-OFF / Number images used: 197772
FSC plot (resolution estimation)

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more